T-cell prolymphocytic leukemia.

Proc (Bayl Univ Med Cent)

Department of Pathology, Section of Hematopathology (Graham, Krause), and the Department of Hematology/Oncology (Cooper), Baylor University Medical Center at Dallas and the Baylor Charles A. Sammons Cancer Center at Dallas.

Published: January 2013

T-cell prolymphocytic leukemia is a rare and unusual malignancy characterized by the proliferation of small- to medium-sized prolymphocytes of postthymic origin with distinctive clinical, morphologic, immunophenotypic, and cytogenetic features. Involvement of the peripheral blood, bone marrow, lymph nodes, liver, spleen, and skin can occur. The clinical course is typically very aggressive with poor response to conventional chemotherapy and short survival rates, and the only potential long-term curative treatment is hematopoietic stem cell transplantation. We report the case of a man with de novo T-cell prolymphocytic leukemia and discuss the distinctive clinical, morphologic, immunophenotypic, and cytogenetic features of this entity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523759PMC
http://dx.doi.org/10.1080/08998280.2013.11928902DOI Listing

Publication Analysis

Top Keywords

t-cell prolymphocytic
12
prolymphocytic leukemia
12
distinctive clinical
8
clinical morphologic
8
morphologic immunophenotypic
8
immunophenotypic cytogenetic
8
cytogenetic features
8
leukemia t-cell
4
leukemia rare
4
rare unusual
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!